ArticlePharmaceuticals (Basel, Switzerland)2024

Comprehensive Ocular and Systemic Safety Evaluation of Polysialic Acid-Decorated Immune Modulating Therapeutic Nanoparticles (PolySia-NPs) to Support Entry into First-in-Human Clinical Trials.

Anitha Krishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.